Income Statement (TTM)
Syros Pharmaceuticals, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 15 | 18 | 20 | 21 | 23 | 24 | 25 | 23 | 15 | 12 | 9 | 9 | 10 | 7 | 4 | 0 |
| Change (%) | 52.42 | 16.22 | 11.26 | 9.58 | 9.83 | 2.72 | 4.62 | -7.15 | -36.51 | -16.89 | -27.84 | -1.43 | 12.96 | -29.73 | -40.58 | -90.70 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 25 | 84 | 112 | 116 | 170 | 115 | 108 | 104 | 96 | 89 | |||||||
| Change (%) | 33.22 | 3.21 | 47.41 | -32.73 | -5.60 | -3.80 | -7.36 | -8.05 | |||||||||
| % of Revenue | 104.32 | 358.55 | 752.31 | 934.21 | 1,908.48 | 1,302.46 | 1,088.50 | 1,490.22 | 2,323.26 | 22,962.95 | |||||||
| Gross Operating Profit | 10 | 15 | 18 | 20 | 21 | 23 | -1 | 25 | -61 | -97 | -103 | -161 | -106 | -98 | -97 | -92 | -88 |
| Change (%) | 52.42 | 16.22 | 11.26 | 9.58 | 9.83 | -104.44 | -2,520.13 | -340.05 | 60.19 | 6.29 | 56.43 | -34.46 | -7.14 | -1.17 | -4.97 | -4.33 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | -4.32 | 100.00 | -258.55 | -652.31 | -834.21 | -1,808.48 | -1,202.46 | -988.50 | -1,390.22 | -2,223.26 | -22,862.95 |
| SG&A | 22 | 21 | 22 | 22 | 22 | 23 | 24 | 26 | 28 | 29 | 30 | 30 | 30 | 28 | 27 | 25 | 23 |
| Change (%) | -2.33 | 2.77 | 1.77 | 0.87 | 2.39 | 5.25 | 5.87 | 10.63 | 3.17 | 1.56 | 0.94 | -1.04 | -4.85 | -4.03 | -6.49 | -8.31 | |
| % of Revenue | 220.50 | 141.29 | 124.94 | 114.28 | 105.20 | 98.08 | 100.49 | 101.70 | 121.18 | 196.90 | 240.60 | 336.56 | 337.91 | 284.64 | 388.76 | 611.74 | 6,028.76 |
| R&D | 61 | 76 | 82 | 93 | 102 | 100 | 80 | 112 | 27 | -58 | |||||||
| Change (%) | 24.05 | 7.18 | 13.48 | 10.36 | -2.19 | -20.05 | 40.69 | -76.15 | |||||||||
| % of Revenue | 619.23 | 503.98 | 464.77 | 474.05 | 477.45 | 425.20 | 330.91 | 445.00 | 114.33 | -652.97 | |||||||
| OpEx | 83 | 97 | 103 | 115 | 125 | 123 | 129 | 138 | 139 | 141 | 145 | 142 | 144 | 136 | 131 | 122 | 112 |
| Change (%) | 17.13 | 6.21 | 11.00 | 8.52 | -1.36 | 5.17 | 6.76 | 0.89 | 1.45 | 2.86 | -2.21 | 1.56 | -5.44 | -3.84 | -7.18 | -8.10 | |
| % of Revenue | 839.73 | 645.27 | 589.70 | 588.33 | 582.66 | 523.28 | 535.73 | 546.70 | 594.06 | 949.21 | 1,174.81 | 1,592.08 | 1,640.37 | 1,373.14 | 1,878.97 | 2,935.00 | 28,991.71 |
| Operating Income | -73 | -82 | -86 | -95 | -103 | -99 | -105 | -113 | -116 | -126 | -133 | -133 | -135 | -126 | -124 | -118 | -112 |
| Change (%) | 12.35 | 4.38 | 10.95 | 8.30 | -3.68 | 5.75 | 7.25 | 2.69 | 9.13 | 5.19 | 0.17 | 1.76 | -6.64 | -1.81 | -5.30 | -5.19 | |
| % of Revenue | -739.73 | -545.27 | -489.70 | -488.33 | -482.66 | -423.28 | -435.73 | -446.70 | -494.06 | -849.21 | -1,074.81 | -1,492.08 | -1,540.37 | -1,273.14 | -1,778.97 | -2,835.00 | -28,891.71 |
| Interest Expense | -1 | -2 | -2 | -3 | -3 | -4 | -4 | -4 | -4 | -4 | -4 | -5 | -5 | -5 | -5 | -5 | -5 |
| Change (%) | 35.45 | 38.84 | 19.45 | 16.49 | 12.85 | 0.23 | 0.26 | 1.73 | 3.51 | 5.83 | 6.81 | 5.37 | 4.12 | 1.76 | 1.99 | 0.17 | |
| % of Revenue | -13.36 | -11.87 | -14.18 | -15.23 | -16.19 | -16.63 | -16.23 | -15.55 | -17.04 | -27.78 | -35.38 | -52.36 | -55.98 | -51.60 | -74.72 | -128.25 | -1,380.83 |
| Net Income | -74 | -84 | -81 | -86 | -93 | -87 | -97 | -109 | -114 | -95 | -93 | -95 | -105 | -165 | -144 | -132 | -98 |
| Change (%) | 14.12 | -3.57 | 6.53 | 7.58 | -6.80 | 12.61 | 12.30 | 3.86 | -16.75 | -1.43 | 1.90 | 10.40 | 56.79 | -12.20 | -8.95 | -25.65 | |
| % of Revenue | -743.66 | -556.80 | -462.00 | -442.38 | -434.30 | -368.52 | -404.00 | -433.67 | -485.12 | -636.12 | -754.40 | -1,065.37 | -1,193.32 | -1,656.34 | -2,069.51 | -3,170.93 | -25,340.67 |
Source: Capital IQ
